Bone mineral density in women with depression

New England Journal of Medicine

Volumn 335, Issue 16, 1996, Pages 1176-1181

  Michelson, David ^a,d   Stratakis, Constantine ^b,c   Hill, Lauren ^a   Reynolds, James ^d   Galliven, Elise ^a   Chrousos, George ^b   Gold, Philip ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL RECEPTOR; GROWTH HORMONE; HYDROCORTISONE; OSTEOCALCIN; PYRIDONE DERIVATIVE;

ADULT; ARTICLE; BODY MASS; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; FRACTURE; GENOTYPE; GROWTH HORMONE RELEASE; HIP; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LUMBAR SPINE; PRIORITY JOURNAL; RADIUS; RISK FACTOR;

ADULT; BONE AND BONES; BONE DENSITY; CASE-CONTROL STUDIES; DENSITOMETRY, X-RAY; DEPRESSIVE DISORDER; FEMALE; HIP JOINT; HUMANS; HYDROCORTISONE; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; RADIUS; REFERENCE VALUES; SPINE;

EID: 0029823520     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199610173351602     Document Type: Article

References (28)

1. Gold PW, Goodwin FK, Chrousos GE Clinical and biochemical manifestations of depression: relation to the neurobiology of stress. N Engl J Med 1988;319:348-53, 413-20. [Erratum, N Engl J Med 1988;319: 1428.]
2. Robins LN, Heizer JE, Weissman MM, et al. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 1984;41:949-58.
3. Mazess RB, Barden H, Ettinger M, Schultz E. Bone density of the radius, spine, and proximal femur in osteoporosis. J Bone Miner Res 1988;3:13-8.
4. Kelly TL. Bone mineral reference databases for American men and women. J Bone Miner Res 1990;5:S249.
5. Morrison NA, Qi JC, Tokita A, et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994;367:284-7.
6. Spector TD, Keen RW, Arden NK, et al. Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: a twin study in Britain. BMJ 1995;310:1357-60.
7. Fleiss JL, Evcritt BS. Comparing the marginal totals of square contingency tables. Br J Math Stat 1971;24:117-23.
8. Schweiger U, Deuschle M, Korner A, et al. Low lumbar bone mineral density in patients with major depression. Am J Psychiatry 1994;151:1691-3.
9. Herzog W, Minne H, Deter C, et al. Outcome of bone mineral density in anorexia nervosa patients 11.7 years after first admission. J Bone Miner Res 1993;8:597-605
10. Abraham G, Friedman RH, Verghese C, de Leon J. Osteoporosis and schizophrenia: can we limit known risk factors? Biol Psychiatry 1995;38: 131-2
11. Halbreich U, Rojansky N, Palter S, et al. Decreased bone mineral density in medicated psychiatric patients. Psychosom Med 1995;57:485-91.
12. Zelissen PMJ, Croughs RJM, van Rijk PP, Raymakers JA. Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease. Ann Intern Med 1994;120:207-10.
13. Kleerekopper M, Schiebinger RJ. Skeletal recovery after treatment of Cushing's: still room for improvement. J Clin Endocrinol Metab 1995;80: 2856-8.
14. Manning PJ, Evans MC, Reid IR. Normal bone mineral density following cure of Cushing's syndrome. Clin Endocrinol (Oxf) 1992;36:229-34.
15. Hermus AR, Smals AG, Swinkels LM, et al. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome. J Clin Endocrinol Metab 1995;80:2859-65.
16. Waller K, Reim J, Fenster L, et al. Bone mass and subtle abnormalities in ovulatory function in healthy women. J Clin Endocrinol Metab 1996; 81:663-8.
17. Keen RW, Major PJ, Lanchbury JS, Spector TD. Vitamin-D-receptorgene polymorphism and bone loss. Lancet 1995;345:990.
18. Hustmyer FG, Peacock M, Hui S, Johnston CC, Christian J. Bone mineral density in relation to polymorphism at the vitamin D receptor locus. J Clin Invest 1994;94:2130-4.
19. Van der Wiel HE, Lips P, Nauta J, Patka P, Haarman HJ, Teule GJ. Loss of bone in the proximal part of the femur following unstable fractures of the leg. J Bone Joint Surg Am 1994;76:230-6.
20. Alekel L, Clasey JL, Fehling PC, et al. Contributions of exercise, body composition, and age to bone mineral density in premenopausal women. Med Sci Sports Exerc 1995;27:1477-85.
21. Leong GM, Mercado-Asis LB, Reynolds JC, et al. Endogenous Cushing syndrome in children causes a marked decrease in bone mineral density and changes in markers of bone turnover that suggest suppression of both ostcoblast and osteoclast activity. In: Program and abstracts of the 77th Annual Meeting of the Endocrine Society, Washington, D.C., June 14-17, 1995. Bethesda, Md.: Endocrine Society Press, 1995:438. abstract.
22. Nielsen HK, Brixen K, Kassem M, Charles P, Mosekilde L. Inhibition of the morning cortisol peak abolishes the expected morning decrease in serum osteocalcin in normal males: evidence of a controlling effect of serum cortisol on the circadian rhythm in serum osteocalcin. J Clin Endocrinol Metab 1992;74:1410-4.
23. Jones G, Sambrook PN. Drug-induced disorders of bone metabolism: incidence, management and avoidance. Drug Saf 1994;10:480-9.
24. Brady LS, Gold PW, Herkenham M, Lynn AB, Whitficld HJ Jr. The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-4 releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications. Brain Res 1992;572:117-25.
25. Brady LS, Whitfield HJ Jr, Fox RJ, Gold PW, Herkenham M. Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain: therapeutic implications. J Clin Invest 1991;87:831-7.
26. Michelson D, Galliven E, Hill L, Gold PW. Chronic imipramine treatment is associated with decreased HPA axis activity in healthy humans. In: Program and abstracts of the 77th Annual Meeting of the Endocrine Society, Washington, D.C., June 14-17, 1995. Bethesda, Md.: Endocrine So ciety Press, 1995:484. abstract.
27. Gold PW, Loriaux DL, Roy A, et al. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease: pathophysiologic and diagnostic implications. N Engl J Med 1986;314: 1329-35.
28. Melton LJ III, Kan SH, Wahner HW, Riggs BL. Lifetime fracture risk: an approach to hip fracture risk assessment based on bone mineral density and age. J Clin Epidemiol 1988;41:985-94.